62 related articles for article (PubMed ID: 23534808)
1. Diagnostic role of survivin in urinary bladder cancer.
Srivastava AK; Singh PK; Srivastava K; Singh D; Dalela D; Rath SK; Goel MM; Brahma Bhatt ML
Asian Pac J Cancer Prev; 2013; 14(1):81-5. PubMed ID: 23534808
[TBL] [Abstract][Full Text] [Related]
2. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine.
Vlahou A; Schellhammer PF; Mendrinos S; Patel K; Kondylis FI; Gong L; Nasim S; Wright GL
Am J Pathol; 2001 Apr; 158(4):1491-502. PubMed ID: 11290567
[TBL] [Abstract][Full Text] [Related]
3. Pilot study for bladder cancer detection with volatile organic compounds using ion mobility spectrometry: a novel urine-based approach.
Heers H; Gut JM; Hofmann R; Flegar L; Derigs M; Huber J; Baumbach JI; Koczulla AR; Boeselt T
World J Urol; 2024 May; 42(1):353. PubMed ID: 38795133
[TBL] [Abstract][Full Text] [Related]
4. Rapid noninvasive detection of bladder cancer using survivin antibody-conjugated gold nanoparticles (GNPs) based on localized surface plasmon resonance (LSPR).
Jazayeri MH; Aghaie T; Nedaeinia R; Manian M; Nickho H
Cancer Immunol Immunother; 2020 Sep; 69(9):1833-1840. PubMed ID: 32350593
[TBL] [Abstract][Full Text] [Related]
5. Survivin as a potential biomarker in the diagnosis of bladder cancer: A systematic review and meta-analysis.
Zhou Z; Zou L; Guan Y; Jiang L; Liu Y; Zhang X; Huang X; Ren H; Li Z; Niu H; Liao H; Zhang X; Pan H; Rong S; Ma H
Urol Oncol; 2024 May; 42(5):133-143. PubMed ID: 38418270
[TBL] [Abstract][Full Text] [Related]
6. Investigation of CCL18 and A1AT as potential urinary biomarkers for bladder cancer detection.
Miyake M; Ross S; Lawton A; Chang M; Dai Y; Mengual L; Alcaraz A; Giacoia EG; Goodison S; Rosser CJ
BMC Urol; 2013 Sep; 13():42. PubMed ID: 24011266
[TBL] [Abstract][Full Text] [Related]
7. Urine cell-free microRNA as biomarkers for transitional cell carcinoma.
Geva GA; Gielchinsky I; Aviv N; Max KEA; Gofrit ON; Gur-Wahnon D; Ben-Dov IZ
BMC Res Notes; 2017 Nov; 10(1):641. PubMed ID: 29187235
[TBL] [Abstract][Full Text] [Related]
8. Value of urinary survivin as a diagnostic marker in bladder cancer.
Abd El-Hakim TF; El-Shafie MK; Abdou AG; Azmy RM; El-Naidany SS; Badr El-Din MO
Anal Quant Cytopathol Histpathol; 2014 Jun; 36(3):121-7. PubMed ID: 25141488
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers for bladder cancer management: present and future.
Ye F; Wang L; Castillo-Martin M; McBride R; Galsky MD; Zhu J; Boffetta P; Zhang DY; Cordon-Cardo C
Am J Clin Exp Urol; 2014; 2(1):1-14. PubMed ID: 25374904
[TBL] [Abstract][Full Text] [Related]
10. Exploring solid-phase proximity ligation assay for survivin detection in urine.
Gleichenhagen J; Arndt C; Casjens S; Töpfer C; Gerullis H; Raiko I; Taeger D; Ecke T; Brüning T; Johnen G
PLoS One; 2022; 17(6):e0270535. PubMed ID: 35767525
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic role of BTA, NMP22, survivin and cytology in urothelial carcinoma.
Gong YW; Wang YR; Fan GR; Niu Q; Zhao YL; Wang H; Svatek R; Rodriguez R; Wang ZP
Transl Cancer Res; 2021 Jul; 10(7):3192-3205. PubMed ID: 35116626
[TBL] [Abstract][Full Text] [Related]
12. Detection of Clinical Mesenchymal Cancer Cells from Bladder Wash Urine for Real-Time Detection and Prognosis.
Khoo BL; Bouquerel C; Durai P; Anil S; Goh B; Wu B; Raman L; Mahendran R; Thamboo T; Chiong E; Lim CT
Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31480265
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of bladder tumor antigen quantitative test in the diagnosis of bladder carcinoma in a schistosoma endemic area.
Muhammad AS; Mungadi IA; Darlington NN; Kalayi GD
Urol Ann; 2019; 11(2):143-148. PubMed ID: 31040598
[TBL] [Abstract][Full Text] [Related]
14. Potential Involvement of
Gil-Kulik P; Krzyżanowski A; Dudzińska E; Karwat J; Chomik P; Świstowska M; Kondracka A; Kwaśniewska A; Cioch M; Jojczuk M; Nogalski A; Kocki J
Oxid Med Cell Longev; 2019; 2019():8727925. PubMed ID: 30774747
[TBL] [Abstract][Full Text] [Related]
15. Performance of urinary survivin as a non-invasive molecular marker of bladdercarcinoma in a schistosomiasis endemic area.
Muhammad AS; Mungadi IA; Ndodu ED; Kalayi GD
Ghana Med J; 2018 Jun; 52(2):74-78. PubMed ID: 30662078
[TBL] [Abstract][Full Text] [Related]
16. Combined use of urinary Survivin detection and liquid-based cytology for the early diagnosis of bladder urothelial carcinoma.
Xu X; Li P; Fu D; Wei Z; Xu S; Xu F; Tian F; Ge J; Zhang Z; Cheng W
Oncol Lett; 2018 May; 15(5):7739-7743. PubMed ID: 29725469
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of urinary survivin as a biomarker for bladder cancer: a systematic review and meta-analysis of published studies.
Liang Z; Xin R; Yu Y; Wang R; Wang C; Liu X
World J Urol; 2018 Sep; 36(9):1373-1381. PubMed ID: 29610963
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a New Survivin ELISA and UBC
Gleichenhagen J; Arndt C; Casjens S; Meinig C; Gerullis H; Raiko I; Brüning T; Ecke T; Johnen G
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29324722
[TBL] [Abstract][Full Text] [Related]
19. Recent Developments in the Search for Urinary Biomarkers in Bladder Cancer.
Leiblich A
Curr Urol Rep; 2017 Nov; 18(12):100. PubMed ID: 29130146
[TBL] [Abstract][Full Text] [Related]
20. Microplate magnetic chemiluminescence immunoassay for detecting urinary survivin in bladder cancer.
Chang Y; Xu J; Zhang Q
Oncol Lett; 2017 Oct; 14(4):4043-4052. PubMed ID: 28943911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
